#China #Shanghai #MXGP #Aphranel #regenerative aesthetics

Aphranel® Brings Regenerative Aesthetics to MXGP Shanghai 2026

Aphranel®, a pioneering brand in regenerative aesthetics established by MOYOM Biotech in China, made a splash as an official partner of the FIM Motocross World Championship held in Shanghai from September 11 to 13, 2026. This collaboration was not just about motorsport; it was also a unique opportunity to introduce the concept of facial aesthetics beyond the medical community.

The aphranel® exhibition booth stood out with its distinctive design, attracting visitors from both motorsport and lifestyle sectors. The booth featured vibrant green colors emblematic of the brand and was adorned with an artistic display of butterflies and motorcycles, seamlessly blending the worlds of athletics and aesthetics. Additionally, attendees could enjoy refreshments at the aphranel Time Café, while engaging with the theme, "Become the master of your state. Dare to take the stage!"

This captivating installation quickly became a hotspot for photo opportunities during the racing weekend. Recognizing the predominately male audience, aphranel® tailored their focus to promote male facial aesthetics. One key innovation showcased was their bio-structural device, MagiCCrystal CaHA, designed for facial contouring in key areas such as the eyebrows, nose, chin, and jawline. This technology not only enhances facial proportion but also maintains the unique features that define each individual's face.

Among notable visitors was Zhang Xue, founder of the renowned Chinese motorcycle brand ZXMOTO, who symbolized the merger of two diverse Chinese brands at the event. The MagiCCrystal technology stems from a comprehensive development program initiated by MOYOM Biotech in 2013, which was supported by China's National Science and Technology Project during its 13th Five-Year Plan. After enduring twelve years of product development and research, MagiCCrystal achieved recognition as a Class III medical device from the NMPA in February 2025, making it China's first calcium hydroxyapatite facial bio-structurer to gain approval.

Having sold over 200,000 syringes and distributed across more than 700 aesthetic clinics in China, the product stands as a testament to technological innovation. The partnership with MXGP provided aplatform for aphranel® to connect its long-term research and technical precision with the automotive industry’s standards, showcasing the valued qualities of biomaterials.

This collaboration is part of a larger initiative designed to elevate global awareness of regenerative aesthetics technology originating from China. Alongside a sustained investment in research and development of biomaterials, aphranel® has extended its endeavors into sports, design, and culture sectors. Following the triumphant showcase in Shanghai, aphranel® is poised for further international expansion. Their philosophy, "Be With Time," underscores their commitment to integrating scientific progress with the evolving notions of contemporary aesthetics.

In summary, aphranel®’s active role at MXGP Shanghai 2026 exemplifies the brand’s innovative approach to intertwining the realms of competitive sports and regenerative aesthetics. With a progressive outlook and cutting-edge technology, aphranel® is set to make influential strides in both the aesthetics and motorsport industries, ultimately enriching the narratives of both fields.